TALZENNA How Supplied/Storage and Handling

(talazoparib)

16 HOW SUPPLIED/STORAGE AND HANDLING

TALZENNA is supplied in strengths and package configurations as described in Table 12:

Table 12. TALZENNA Capsules
Package Configuration	Capsule Strength (mg)	NDC	Print
Bottles of 30 capsules	0.1	NDC 0069-1031-30	White cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black).
Bottles of 30 capsules	0.25	NDC 0069-0296-30	Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black).
Bottles of 30 capsules	0.35	NDC 0069-1235-30	Ivory cap (printed with “Pfizer” in black) and an ivory body (printed with “TLZ 0.35” in black).
Bottles of 30 capsules	0.5	NDC 0069-1501-30	Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black).
Bottles of 30 capsules	0.75	NDC 0069-1751-30	Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black).
Bottles of 30 capsules	1	NDC 0069-1195-30	Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black).

Storage

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature].

Find TALZENNA medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TALZENNA Quick Finder

Medication Guide

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

TALZENNA is supplied in strengths and package configurations as described in Table 12:

Table 12. TALZENNA Capsules
Package Configuration	Capsule Strength (mg)	NDC	Print
Bottles of 30 capsules	0.1	NDC 0069-1031-30	White cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black).
Bottles of 30 capsules	0.25	NDC 0069-0296-30	Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black).
Bottles of 30 capsules	0.35	NDC 0069-1235-30	Ivory cap (printed with “Pfizer” in black) and an ivory body (printed with “TLZ 0.35” in black).
Bottles of 30 capsules	0.5	NDC 0069-1501-30	Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black).
Bottles of 30 capsules	0.75	NDC 0069-1751-30	Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black).
Bottles of 30 capsules	1	NDC 0069-1195-30	Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black).

Storage

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature].

Prescribing Information

Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

TALZENNA is supplied in strengths and package configurations as described in Table 12:

Table 12. TALZENNA Capsules
Package Configuration	Capsule Strength (mg)	NDC	Print
Bottles of 30 capsules	0.1	NDC 0069-1031-30	White cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black).
Bottles of 30 capsules	0.25	NDC 0069-0296-30	Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black).
Bottles of 30 capsules	0.35	NDC 0069-1235-30	Ivory cap (printed with “Pfizer” in black) and an ivory body (printed with “TLZ 0.35” in black).
Bottles of 30 capsules	0.5	NDC 0069-1501-30	Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black).
Bottles of 30 capsules	0.75	NDC 0069-1751-30	Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black).
Bottles of 30 capsules	1	NDC 0069-1195-30	Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black).

Storage

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature].

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.